The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
- Wednesday, September 9, 2020, 7:04
- Finance
- Add a comment
RYE BROOK, N.Y., Sept. 9, 2020 /PRNewswire/ — With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first…
About the Author
adminasapcorp has written 41546 stories on this site.